Enhancing Targeted Therapy in Breast Cancer by Ultrasound-Responsive Nanocarriers

Currently, the response to cancer treatments is highly variable, and severe side effects and toxicity are experienced by patients receiving high doses of chemotherapy, such as those diagnosed with triple-negative breast cancer. The main goal of researchers and clinicians is to develop new effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Edwards, Isaiah A., De Carlo, Flavia, Sitta, Juliana, Varner, William, Howard, Candace M., Claudio, Pier Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053544/
https://www.ncbi.nlm.nih.gov/pubmed/36982548
http://dx.doi.org/10.3390/ijms24065474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053544/
https://www.ncbi.nlm.nih.gov/pubmed/36982548
http://dx.doi.org/10.3390/ijms24065474

Ejemplares similares